Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dennis Purcell
AddedMar 31, 2024
UpdatedJun 28, 2026
Dennis Purcell

Dennis Purcell

Board Member, University of Delaware

CrunchbaseLinkedIn

Dennis Purcell's Career

University of Delaware
University of Delaware

Newark, DE, US

Board Member· Board
BioScience Managers
BioScience Managers

Melbourne, Victoria, AU

Board Member· Board
Aisling Capital
Aisling Capital

New York City, NY, US

Founder
Embera Neurotherapeutics
Embera Neurotherapeutics

Sudbury, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dennis Purcell's Career

University of Delaware
University of Delaware
GovernmentGovernment$4.8M4.9k1743Newark, DE, US
Board Member· Board

Leadership at University of Delaware

Eric FurstEric FurstBoard Member
Michael GeltzeilerMichael GeltzeilerBoard Member
Yushan YanYushan YanBoard Member
Mariah CalagioneMariah CalagioneBoard Member
Fred DeMiccoFred DeMiccoBoard Member
Terri L. KellyTerri L. KellyBoard Member

Similar to University of Delaware

I.Lab at UVAI.Lab at UVACharlottesville, VA, USCoaching, Incubationest. 2016I.Lab at UVACharlottesville, VA, US · est. 2016

i.Lab: A University-wide initiative fostering entrepreneurship and innovation through coaching and incubation.

Government7
UM Center for Innovation and EntrepreneurshipUM Center for Innovation and EntrepreneurshipOxford, MS, USEntrepreneurship, Incubationest. 2014UM Center for Innovation and EntrepreneurshipOxford, MS, US · est. 2014

Oxford-based UM Center for Innovation and Entrepreneurship fosters new business and economic growth.

Government1
Idea Center at the University of Notre DameIdea Center at the University of Notre DameSouth Bend, IN, USConsulting, Incubationest. 2017Idea Center at the University of Notre DameSouth Bend, IN, US · est. 2017

IDEA Center: Notre Dame's core hub for tech innovation, commercialization, and entrepreneurship.

Government118
Georgia Tech Create-XGeorgia Tech Create-XAtlanta, GA, USStartup Programsest. 2014Georgia Tech Create-XAtlanta, GA, US · est. 2014

CREATE-X at Georgia Tech empowers students to launch startups, fostering entrepreneurial confidence.

Government · $2.1M29
BioScience Managers
BioScience Managers
Investment FirmInvestment Firm302003Melbourne, Victoria, AU
Board Member· Board

Leadership at BioScience Managers

Nicole VitulloNicole VitulloBoard Member
Jeremy Curnock CookJeremy Curnock CookBoard Member
Matt McNamaraMatt McNamaraBoard Member
Alan CaineyAlan CaineyBoard Member
Jonathan BuckleyJonathan BuckleyCo-Founder
Jonathan HeppleJonathan HeppleCo-Founder
Aisling Capital
Aisling Capital
Investment FirmInvestment Firm202000New York City, NY, US
Founder
Embera Neurotherapeutics
Embera Neurotherapeutics
Series A$28.4M112005Sudbury, MA, US
Board Member· Board

Leadership at Embera Neurotherapeutics

Bob LinkeBob LinkeCEO
Nicholas GoedersNicholas GoedersFounder

Similar to Embera Neurotherapeutics

Amygdala NeurosciencesAmygdala NeurosciencesPalo Alto, CA, USBiopharmaceuticalsest. 2015Amygdala NeurosciencesPalo Alto, CA, US · est. 2015

Amygdala Neurosciences Inc: A California-based biopharmaceutical company.

Seed · $8.9M30
Encepheal TherapeuticsEncepheal TherapeuticsWinston-Salem, NC, USPharmaceuticalsest. 2015Encepheal TherapeuticsWinston-Salem, NC, US · est. 2015

EncepHeal: Innovating non-addictive meds for substance abuse treatment.

Angel · $300k
NeuroTherapeutics PharmaNeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30
Neurana PharmaceuticalsNeurana PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2013Neurana PharmaceuticalsSan Diego, CA, US · est. 2013

Neurana Pharmaceuticals: A US-based specialty pharma company innovating treatments for CNS diseases.

Series A · $60M5

Dennis Purcell's Co-Investors

Robert Parkinson IIIRobert Parkinson IIICo-invested · Cellevolve Bio SeedEric M StoneEric M StoneCo-invested · Cellevolve Bio SeedJonathan FassbergJonathan FassbergCo-invested · Cellevolve Bio SeedAnshul MangalAnshul MangalCo-invested · Cellevolve Bio SeedAnshul MangalAnshul MangalCo-invested · Cellevolve Bio Seed

Dennis Purcell's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Dennis Purcell

Walter YoungWalter YoungBoard Member · NanoceroxDarren HiteDarren HiteFounder · Transformational HealthcareJustin CaldbeckJustin CaldbeckCo-Founder · Binary CapitalJohn CaselliJohn CaselliBoard Member · DirectShiftsJack EgglestonJack EgglestonFounder · Charmides CapitalJohn PalmerJohn PalmerBoard Member · Gulfsouth Capital